PCS
RMD icon

Personal CFO Solutions’s ResMed RMD Stock Holding History

Personal CFO Solutions’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Sell
1,151
-44
-4% -$11K 0.04% 429
2025
Q4 		$288K Sell
1,195
-20
-2% -$5.12K 0.05% 381
2025
Q3 		$333K Sell
1,215
-30
-2% -$8.2K 0.06% 317
2025
Q2 		$321K Sell
1,245
-107
-8% -$25.5K 0.06% 310
2025
Q1 		$303K Buy
1,352
+61
+5% +$14.2K 0.06% 314
2024
Q4 		$295K Buy
+1,291
New +$311K 0.06% 330
2023
Q3 		– Sell
-2,356
Closed -$515K – 491
2023
Q2 		$515K Buy
2,356
+54
+2% +$12K 0.1% 195
2023
Q1 		$504K Sell
2,302
-1,329
-37% -$288K 0.1% 194
2022
Q4 		$756K Sell
3,631
-86
-2% -$18.9K 0.16% 122
2022
Q3 		$811K Sell
3,717
-1,237
-25% -$282K 0.2% 95
2022
Q2 		$1.04M Sell
4,954
-128
-3% -$27.3K 0.24% 72
2022
Q1 		$1.23M Sell
5,082
-127
-2% -$30.7K 0.24% 82
2021
Q4 		$1.36M Buy
5,209
+77
+2% +$20K 0.25% 74
2021
Q3 		$1.35M Buy
5,132
+78
+2% +$21.3K 0.28% 72
2021
Q2 		$1.25M Sell
5,054
-588
-10% -$124K 0.26% 77
2021
Q1 		$1.09M Buy
5,642
+104
+2% +$20.9K 0.24% 82
2020
Q4 		$1.18M Sell
5,538
-90
-2% -$17.9K 0.29% 77
2020
Q3 		$1K Buy
5,628
+14
+0.2% +$2.58K 0.33% 113
2020
Q2 		$1.08M Buy
5,614
+45
+0.8% +$7.36K 0.32% 72
2020
Q1 		$820K Buy
5,569
+21
+0.4% +$3.35K 0.29% 80
2019
Q4 		$859K Buy
5,548
+246
+5% +$35.5K 0.25% 85
2019
Q3 		$716K Buy
+5,302
New +$695K 0.29% 84

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Personal CFO Solutions's RMD Position: Q1 2026 in Review

Personal CFO Solutions reduced its ResMed (RMD) stake by 3.7% in Q1 2026, selling an estimated $11K and leaving 1,151 shares worth $258K. The position accounts for 0.04% of the portfolio, ranked #429.

Personal CFO Solutions first reported a position in RMD in Q3 2019 and has held it in 22 quarters since. The position peaked at $1.36M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Personal CFO Solutions held 1,151 shares of ResMed worth $258K as of Q1 2026.
  • Personal CFO Solutions sold 44 ResMed shares in Q1 2026, an estimated $11K.
  • ResMed made up 0.04% of Personal CFO Solutions's portfolio in Q1 2026, its #429 holding.
  • Personal CFO Solutions first reported a position in ResMed in Q3 2019 and has held it in 22 quarters since.
  • Personal CFO Solutions's ResMed position peaked at $1.36M in Q4 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.